Ixabepilone in Treating Patients With Recurrent or Persistent Endometrial Cancer
Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
Drugs used in chemotherapy, such as ixabepilone, work in different ways to stop tumor cells
from dividing so they stop growing or die. This phase II trial is studying how well
ixabepilone works in treating patients with recurrent or persistent endometrial cancer.